Applying Population Management Best Practices to Preventative Genomic Medicine Trial
Part of paid clinical trials in Denver, Colorado.
- Sponsor
- University of Washington
- Study ID
- NCT07053813
- Status
- Enrolling By Invitation
Conditions
- Neoplastic Syndromes, Hereditary
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Web resources — BEHAVIORALMailed educational resources through portal and USPS mail
- Personalized outreach — BEHAVIORALPhone call to discuss due and overdue screening and other personalized risk management recommendations
Study Details
Preventive genomic medicine, particularly identification of individuals with inherited cancer risk, can improve longevity and quality of life, yet adherence to risk management following cancer genomic testing is poor. The proposed research refines and evaluates two highly scalable population management interventions, web resources and personalized outreach, designed to improve access and use of recommended risk management following cancer genetic testing. Research activities will be conducted in a vertically integrated health system and federally qualified health center and will address post-testing quality and patient safety concerns that are minimizing patient benefit and slowing investments in real world genomic medicine implementation.
Key Dates
- Start date
- Jul 1, 2025
- Status verified
- Jun 2025
- Primary completion
- Jul 1, 2027
- Completion
- Jul 1, 2028
Study Design
- Enrollment
- 900 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- No Intervention: Usual careNo intervention
- Experimental: Web resourcesIndividuals randomized to web resources will be sent materials refined in Aim 1 (via patient portal and USPS mail) within 1-2 weeks after their birthday. Messages will be sent in English or preferred language noted in the EHR.
- Experimental: Personalized outreachIndividuals randomized to personalized outreach will be contacted by the care coordinator in their birthday month for a brief phone call discussing due and overdue screening. The coordinator will attempt to contact patients up to 3 times to complete the phone conversation before considering them opting out of the intervention. If needed, the coordinator can place orders and pending referrals for PCP signature.
Primary Outcome Measure
Proportion time covered [ Time Frame: 12 months following randomization ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Denver Health | Denver | Colorado | 80204 | - |
| Kaiser Northwest | Portland | Oregon | 97227 | - |